BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1246 related articles for article (PubMed ID: 25365095)

  • 1. Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.
    Castrejón I; Tani C; Jolly M; Huang A; Mosca M
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-85-95. PubMed ID: 25365095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
    Askanase AD; Castrejón I; Pincus T
    J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome measures to be used in clinical trials in systemic lupus erythematosus.
    Strand V; Gladman D; Isenberg D; Petri M; Smolen J; Tugwell P
    J Rheumatol; 1999 Feb; 26(2):490-7. PubMed ID: 9972993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measures of disease activity and damage in pediatric systemic lupus erythematosus: British Isles Lupus Assessment Group (BILAG), European Consensus Lupus Activity Measurement (ECLAM), Systemic Lupus Activity Measure (SLAM), Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), Physician's Global Assessment of Disease Activity (MD Global), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI; SDI).
    Lattanzi B; Consolaro A; Solari N; Ruperto N; Martini A; Ravelli A
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11():S112-7. PubMed ID: 22588739
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review.
    Castrejón I; Rúa-Figueroa I; Rosario MP; Carmona L
    Reumatol Clin; 2014; 10(5):309-20. PubMed ID: 25022441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus.
    Ward MM; Marx AS; Barry NN
    J Rheumatol; 2000 Mar; 27(3):664-70. PubMed ID: 10743805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).
    Romero-Diaz J; Isenberg D; Ramsey-Goldman R
    Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11(0 11):S37-46. PubMed ID: 22588757
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices.
    Griffiths B; Mosca M; Gordon C
    Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):685-708. PubMed ID: 16150398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada.
    Bourré-Tessier J; Clarke AE; Mikolaitis-Preuss RA; Kosinski M; Bernatsky S; Block JA; Jolly M
    J Rheumatol; 2013 Aug; 40(8):1327-33. PubMed ID: 23772082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Systemic Lupus Erythematosus Responder Index (SRI); a new SLE disease activity assessment.
    Luijten KM; Tekstra J; Bijlsma JW; Bijl M
    Autoimmun Rev; 2012 Mar; 11(5):326-9. PubMed ID: 21958603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies.
    Karlson EW; Daltroy LH; Rivest C; Ramsey-Goldman R; Wright EA; Partridge AJ; Liang MH; Fortin PR
    Lupus; 2003; 12(4):280-6. PubMed ID: 12729051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the assessment of lupus disease activity and damage.
    Rao V; Gordon C
    Curr Opin Rheumatol; 2014 Sep; 26(5):510-9. PubMed ID: 25010438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study.
    Ramirez GA; Canti V; Moiola L; Magnoni M; Rovere-Querini P; Coletto LA; Dagna L; Manfredi AA; Bozzolo EP
    Int J Rheum Dis; 2019 Sep; 22(9):1752-1761. PubMed ID: 31379114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between the Modified Systemic Lupus Erythematosus Disease Activity Index 2000 and the European Consensus Lupus Activity Measurement in juvenile systemic lupus erythematosus.
    Sato JO; Corrente JE; Saad-Magalhães C
    Lupus; 2016 Nov; 25(13):1479-1484. PubMed ID: 27230556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From BILAG to BILAG-based combined lupus assessment-30 years on.
    Murphy CL; Yee CS; Gordon C; Isenberg D
    Rheumatology (Oxford); 2016 Aug; 55(8):1357-63. PubMed ID: 26589244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.
    Moore AD; Clarke AE; Danoff DS; Joseph L; Bélisle P; Neville C; Fortin PR
    J Rheumatol; 1999 Jun; 26(6):1285-90. PubMed ID: 10381044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus.
    Leosuthamas P; Narongroeknawin P; Chaiamnuay S; Asavatanabodee P; Pakchotanon R
    Int J Rheum Dis; 2023 Apr; 26(4):667-672. PubMed ID: 36802112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus.
    Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G
    J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
    Gladman DD; Goldsmith CH; Urowitz MB; Bacon P; Bombardier C; Isenberg D; Kalunian K; Liang MH; Maddison P; Nived O
    J Rheumatol; 1994 Aug; 21(8):1468-71. PubMed ID: 7983648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.